Methyl 2-(3-Oxo-1,2,3,4-Tetrahydroquinoxalin-2-Yl)Acetate 50702 Radiopharmaceuticals: Strontium iodide is employed

Radiopharmaceuticals: Strontium iodide is employed in the development of radiopharmaceuticals for targeted cancer therapies

providing insights into their therapeutic potential and safety profiles

helping to protect crops from fungal diseases

especially those targeting metabolic disorders

Methyl 2-(3-Oxo-1,2,3,4-Tetrahydroquinoxalin-2-Yl)Acetate 50702 Radiopharmaceuticals: Strontium iodide is employedMethyl 2 (3 Oxo 1,2,3,4 Tetrahydroquinoxalin 2 Yl)Acetate is widely utilized in research focused on: Pharmaceutical Development: This compound serves as a key intermediate in the synthesis of various pharmaceutical agents, particularly those targeting neurological disorders, enhancing drug efficacy and specificity. Biochemical Research: It is employed in studies investigating enzyme activity and metabolic pathways, providing insights into cellular